Introduction: Several new treatment modalities are being developed for lysosomal storage disorders (LSDs), including gene therapy. As the currently available treatment options and their influence on disease progression differ greatly within the spectrum of LSDs, willingness to undergo gene therapy might vary among patients with LSDs and/or their representatives. The width of the LSD spectrum is illustrated by the differences between type 1 Gaucher disease, Fabry disease and Mucopolysaccharidosis type III (MPS III).
View Article and Find Full Text PDFToday's medical students invest large amounts of time and energy into building what is believed to be the ideal résumé to ensure admission to residency programmes. In this clinical lesson, we present three Dutch pre-graduate medical students who approach CV-building and the perceived pressure to be a typical overachiever on paper in different manners. In addition, we conducted a survey among the heads of 160 Dutch residency programmes.
View Article and Find Full Text PDF© LitMetric 2025. All rights reserved.